Diseases

NEC, Biomy collaborate on AI-driven digital pathology platform
By LabPulse.com staff writers
NEC and Biomy have formed a joint marketing partnership to develop and expand artificial intelligence (AI)-based analytical digital pathology platforms.
January 10, 2025
Business Handshake Intelligence Social
Mindray launches AI-enabled cellular analysis line
By LabPulse.com staff writers
The system is designed to mitigate the risk of low platelet count, according to the company.
January 10, 2025
Blood Cells Vessel Social
Oxford University team develops early-detection multicancer test
By LabPulse.com staff writers
Oxford University researchers have developed a promising liquid biopsy test that uses machine learning to detect six forms of cancer in their earliest stages.
January 9, 2025
Cancer Cell Microenvironment Social
Myriad expands scope of whole genome sequencing-based MRD projects
By LabPulse.com staff writers
The goal of the studies is to generate evidence that supports national guideline inclusion and healthcare provider adoption.
January 7, 2025
Dna Cancer Cell Social
Geneoscopy raises $105M for CRC, IBD test drive
By LabPulse.com staff writers
Geneoscopy has raised $105 million in a Series C funding round led by Bio-Rad Laboratories.
January 8, 2025
Colorectal Cancer Social
University of Iowa pathologists suggest best-practice advisory for SRA testing
By Liz Carey
Utilization analysis shows confirmatory serotonin release assays may be overused.
January 7, 2025
Blood Cells Vessel Social
Sysmex America, DiaCarta highlight FIT CRC screening tests
By LabPulse.com staff writers
Developments that may signal increased fecal immunochemical testing in colorectal cancer screening worldwide in 2025.
January 6, 2025
Colorectal Cancer Social
NIST develops genetic material for validating H5N1 diagnostic tests
By LabPulse.com staff writers
The National Institute of Standards and Technology (NIST) has developed a nonhazardous synthetic genetic material designed to validate diagnostic tests for the H5N1 virus, commonly known as bird flu.
January 3, 2025
Avian Influenza A Virus Social
BioNTech reaches agreement with NIH, Penn on COVID-19 vaccine royalties
By LabPulse.com staff writers
German company BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania (Penn) over royalty payments for its COVID-19 vaccine.
December 27, 2024
Agreement Legal Settlement Social
Health Canada grants approval for MedMira's HIV and syphilis test
By LabPulse.com staff writers
Regulatory body Health Canada has granted approval to MedMira's point-of-care test for HIV and syphilis.
December 27, 2024
Syphilis Treponema Bacteria Social
Quest to provide services for Mainz Biomed CRC test clinical trials
By LabPulse.com staff writers
Mainz Biomed has made an agreement with Quest Diagnostics in which Quest will support the commercialization of Mainz Biomed’s next-generation ColoAlert colorectal cancer (CRC) screening test.
December 19, 2024
Colorectal Cancer Social
Labcorp launches H5N1 avian flu test in the U.S.
By LabPulse.com staff writers
Labcorp has launched its new molecular diagnostic test for patients suspected of infection with the H5N1 virus responsible for the current outbreak of H5 avian flu.
December 19, 2024
Avian Influenza A Virus Social
Page 1 of 294
Next Page